Community Resource

AASLD IDSA New Guidance

What’s New, Updates, and Changes to the Guidance This version of the guidance has been updated to reflect several important developments, including the recent approvals of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. Updated recommendations reflecting these approvals are Read more…

By HepCAP, ago

New Hep C Drugs posted news about another cheaper Hep C drug. Hopefully the market will continue to compete the prices down! Learn more about the FDA drug pipline at Mavyret

By HepCAP, ago